Mj Biotech, Inc.  (BNBI)

The rising company from the Biotechnology & Pharmaceuticals market the BNBI reported the fourth quarter of 2018, results

BNBI announced fourth quarter of 2018 operating profit of $5.761972 millions

Published Nov 30 -0001
Goran Soko / CSIMarket.com Contributer

4260787593_3a6dbaac67_z The Biotechnology & Pharmaceuticals industry insiders continue to analyze the fourth quarter of 2018 numbers. Today those insiders observe operating profit of $5.761972 millions, from the Mj Biotech, Inc., as it hasn't stated any revenue yet, for the own October to December 31 2018 reporting period.

The Net income appears to be very well in the most recent quarter. Mj Biotech, Inc. has enhanced net income to $5.353 millions, from $0.000 millions, in the fourth quarter of 2017.

the Biotechnology & Pharmaceuticals company reported shortfall of $-0.84 millions and Revenues of $0.00 millions in the financial year 2018.

Mj Biotech, Inc. announced further break-even in proportion to $-0.04 in the previous financial year, while by 0 % from $0.00 millions a year before.

Mj Biotech's Asset Turnover

Mj Biotech's ROE

Other BNBI's Earnings Reports

Other BNBI's Earnings Reports


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071